Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
January 19 2021 - 9:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2021
Commission File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal
executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY NOTE
On
January 19, 2021, Medigus Ltd. issued a press release titled: “Medigus Announces Exercise and Closing of Underwriter’s
Over-Allotment Option” A copy of this press release is furnished herewith as exhibit 99.1.
This
report on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-238162 and
No. 333-237774)
and Form S-8 (File No. 333-206803,
No. 333-221019
and No. 333-229429).
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: January 19, 2021
|
By:
|
/s/ Liron Carmel
|
|
|
Liron Carmel
|
|
|
Chief Executive Officer
|
EXHIBIT INDEX
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024